Skip to main content

Rapid therapy development through Open nCoronavirus Vaccine Platform

Project description

A DNA vaccine platform against SARS-CoV-2

Call for proposal

H2020-SC1-PHE-CORONAVIRUS-2020
See other projects for this call

Funding Scheme

RIA - Research and Innovation action

Coordinator

KAROLINSKA INSTITUTET
Address
Nobels Vag 5
17177 Stockholm
Sweden
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 400 000

Participants (6)

JUSTUS-LIEBIG-UNIVERSITAET GIESSEN
Germany
EU contribution
€ 200 000
Address
Ludwigstrasse 23
35390 Giessen
Activity type
Higher or Secondary Education Establishments
FOLKHALSOMYNDIGHETEN
Sweden
EU contribution
€ 400 000
Address
Nobels Vag 18
171 82 Solna
Activity type
Other
IGEA SPA
Italy
EU contribution
€ 200 000
Address
Via Parmenide 10A
41012 Carpi Mo
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
COBRA BIOPHARMA MATFORS AB
Sweden
EU contribution
€ 1 200 000
Address
Box 219
864 23 Matfors
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
ADLEGO BIOMEDICAL AB
Sweden
EU contribution
€ 200 000
Address
Box 42
751 03 Uppsala
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
REGION STOCKHOLM
Sweden
EU contribution
€ 400 000
Address
Hantverkargatan 45
104 22 Stockholm
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)